These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 20390694)

  • 21. A comparison of four buprenorphine dosing regimens in the treatment of opioid dependence.
    Petry NM; Bickel WK; Badger GJ
    Clin Pharmacol Ther; 1999 Sep; 66(3):306-14. PubMed ID: 10511067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical use of methadone.
    Layson-Wolf C; Goode JV; Small RE
    J Pain Palliat Care Pharmacother; 2002; 16(1):29-59. PubMed ID: 14650449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions on mixing diazepam with methadone or buprenorphine in maintenance patients.
    Lintzeris N; Mitchell TB; Bond A; Nestor L; Strang J
    J Clin Psychopharmacol; 2006 Jun; 26(3):274-83. PubMed ID: 16702892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prescribing to drug misusers in practice--often effective, but rarely straightforward.
    Seivewright N; Iqbal MZ
    Addict Biol; 2002 Jul; 7(3):269-77. PubMed ID: 12126485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial.
    Wedam EF; Bigelow GE; Johnson RE; Nuzzo PA; Haigney MC
    Arch Intern Med; 2007 Dec; 167(22):2469-75. PubMed ID: 18071169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial.
    Strain EC; Bigelow GE; Liebson IA; Stitzer ML
    JAMA; 1999 Mar; 281(11):1000-5. PubMed ID: 10086434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
    Giacomuzzi S; Kemmler G; Ertl M; Riemer Y
    Subst Use Misuse; 2006; 41(2):223-44. PubMed ID: 16393744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selection of the initial methadone regimen for the management of iatrogenic opioid abstinence syndrome in critically ill children.
    Johnson PN; Boyles KA; Miller JL
    Pharmacotherapy; 2012 Feb; 32(2):148-57. PubMed ID: 22392424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methadone induction doses: are our current practices safe?
    Srivastava A; Kahan M
    J Addict Dis; 2006; 25(3):5-13. PubMed ID: 16956864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral methadone for chronic noncancer pain: a systematic literature review of reasons for administration, prescription patterns, effectiveness, and side effects.
    Sandoval JA; Furlan AD; Mailis-Gagnon A
    Clin J Pain; 2005; 21(6):503-12. PubMed ID: 16215336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence.
    Eap CB; Buclin T; Baumann P
    Clin Pharmacokinet; 2002; 41(14):1153-93. PubMed ID: 12405865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methadone use in pregnancy: evidence of progression in the severity of addiction.
    Devarajah S; Sullivan JV; Purcell A; Tutty S; Sinha C; Lindow SW
    J Obstet Gynaecol; 2012 Nov; 32(8):753-5. PubMed ID: 23075348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Syncope: a tale of two triggers.
    Katz DF; Varosy PD; Masoudi FA
    JAMA Intern Med; 2013 Sep; 173(16):1543-4. PubMed ID: 24030761
    [No Abstract]   [Full Text] [Related]  

  • 34. [Methadone and thyroid disorders].
    Gundersen R
    Tidsskr Nor Laegeforen; 2001 Nov; 121(29):3445. PubMed ID: 11826797
    [No Abstract]   [Full Text] [Related]  

  • 35. Maternal methadone dosing schedule and fetal neurobehaviour.
    Jansson LM; Dipietro JA; Velez M; Elko A; Knauer H; Kivlighan KT
    J Matern Fetal Neonatal Med; 2009 Jan; 22(1):29-35. PubMed ID: 19085624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A naturalistic study on ending blind dosing in a methadone maintenance clinic in Israel.
    Bleich A; Gelkopf M; Hayward R; Adelson M
    Drug Alcohol Depend; 2001 Jan; 61(2):191-4. PubMed ID: 11137284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methadone overdose and cardiac arrhythmia potential: findings from a review of the evidence for an American Pain Society and College on Problems of Drug Dependence clinical practice guideline.
    Chou R; Weimer MB; Dana T
    J Pain; 2014 Apr; 15(4):338-65. PubMed ID: 24685459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends in the average prescribed dose of methadone: more than a proxy for the evolution of severity of opioid dependence.
    Trujols J; Siñol N; Pérez De Los Cobos J
    J Obstet Gynaecol; 2013 May; 33(4):430. PubMed ID: 23654341
    [No Abstract]   [Full Text] [Related]  

  • 39. Safe methadone induction and stabilization: report of an expert panel.
    Baxter LE; Campbell A; Deshields M; Levounis P; Martin JA; McNicholas L; Payte JT; Salsitz EA; Taylor T; Wilford BB
    J Addict Med; 2013; 7(6):377-86. PubMed ID: 24189172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Divided doses for methadone maintenance.
    Modesto-Lowe V
    Am J Psychiatry; 2008 Oct; 165(10):1358; author reply 1358-9. PubMed ID: 18829892
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.